Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 212,161,680
  • Shares Outstanding, K 5,556,880
  • Annual Sales, $ 51,750 M
  • Annual Income, $ 16,273 M
  • 60-Month Beta 0.66
  • Price/Sales 4.02
  • Price/Cash Flow 9.11
  • Price/Book 3.22
Trade PFE with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.70
  • Number of Estimates 5
  • High Estimate 0.75
  • Low Estimate 0.60
  • Prior Year 0.75
  • Growth Rate Est. (year over year) -6.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.52 +7.49%
on 09/25/20
38.85 -1.72%
on 10/19/20
+2.18 (+6.06%)
since 09/23/20
3-Month
35.38 +7.93%
on 09/21/20
39.45 -3.22%
on 07/29/20
-0.23 (-0.60%)
since 07/23/20
52-Week
27.88 +36.94%
on 03/23/20
40.97 -6.81%
on 01/24/20
+1.41 (+3.83%)
since 10/23/19

Most Recent Stories

More News
Worldwide Dermatological Therapeutics Industry to 2028 - Rise in Awareness Levels of Disease Origin and Progression Presents Opportunities

, /PRNewswire/ -- The report has been added to offering.

AGN : 193.02 (+0.02%)
AMGN : 227.16 (-0.36%)
GSK : 35.29 (+0.57%)
MRK : 79.83 (+0.78%)
NVS : 84.43 (+0.02%)
PFE : 38.18 (+2.00%)
Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus

The healthcare is expected to witness substantial earnings growth of 5.1% in the third quarter, representing the second strongest sector this earnings season.

JNJ : 145.24 (+0.11%)
PFE : 38.18 (+2.00%)
GILD : 60.79 (+0.20%)
MRK : 79.83 (+0.78%)
LLY : 142.38 (+0.52%)
BMY : 60.13 (-1.04%)
AMGN : 227.16 (-0.36%)
ABBV : 84.34 (+0.04%)
XLV : 107.82 (+0.37%)
VHT : 209.85 (+0.46%)
IYH : 232.62 (+0.37%)
FHLC : 54.18 (+0.50%)
Thinking about buying stock in Pfizer, Delta Air Lines, Norwegian Cruise Line, CTI BioPharma, or Honeywell?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PFE, DAL, NCLH, CTIC, and HON.

CTIC : 3.50 (+4.79%)
DAL : 34.00 (+0.83%)
HON : 175.54 (-0.74%)
NCLH : 18.35 (+3.61%)
PFE : 38.18 (+2.00%)
Novartis (NVS) Gets Orphan Drug Tag for Huntington's Disease Drug

Novartis (NVS) gets orphan drug designation for branaplam (LMI070) in Huntington's disease.

PFE : 38.18 (+2.00%)
MRK : 79.83 (+0.78%)
NVS : 84.43 (+0.02%)
BMY : 60.13 (-1.04%)
Diagnostic Testing Capabilities Improve in the Face of Global Turmoil

, /PRNewswire/ -- While biotech companies work on vaccines and possible treatments and medical device companies focus on patient monitoring solutions, many others have been working on improving testing...

TOMDF : 0.0580 (-10.77%)
ADIL : 1.8000 (-6.74%)
PFE : 38.18 (+2.00%)
JNJ : 145.24 (+0.11%)
ABT : 107.79 (-1.54%)
Is a Beat in Store for Glaxo (GSK) This Earnings Season?

Glaxo's (GSK) Pharmaceutical and Consumer Healthcare segments are likely to have driven third-quarter sales. Results will provide clarity on the impact of coronavirus on the company's vaccine business....

PFE : 38.18 (+2.00%)
MRK : 79.83 (+0.78%)
GSK : 35.29 (+0.57%)
NVS : 84.43 (+0.02%)
Earnings scheduled for the week of 10/26/2020

Major companies tentatively scheduled to post quarterly earnings next week:

PFE : 38.18 (+2.00%)
Ocular Inflammation Treatment Market Research Services Industry to 2025 – COVID-19 Impact and Recovery

The is expected to exceed more than US$ 500 Billion by 2024 at a CAGR of 6% in the given forecast period.

AKRX : 0.0900 (-51.01%)
ALIM : 4.51 (-2.17%)
AGN : 193.02 (+0.02%)
NVS : 84.43 (+0.02%)
PFE : 38.18 (+2.00%)
VRX.TO : 30.80 (-3.33%)
Is Canopy Growth a Buy on its Recent Dip?

Canada has already legalized recreational cannabis and the United States might follow the same route if Biden wins the White House. However, market volatility and pandemic-driven obstacles have resulted...

CGC : 19.73 (-2.81%)
NVS : 84.43 (+0.02%)
PFE : 38.18 (+2.00%)
JNJ : 145.24 (+0.11%)
Pfizer Inc Falls 1.56% on Heavy Volume: Watch For Potential Rebound

Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $37.03 to a high of $37.54. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $37.06 on...

PFE : 38.18 (+2.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional...

See More

Key Turning Points

2nd Resistance Point 38.68
1st Resistance Point 38.43
Last Price 38.18
1st Support Level 37.79
2nd Support Level 37.40

See More

52-Week High 40.97
Last Price 38.18
Fibonacci 61.8% 35.97
Fibonacci 50% 34.42
Fibonacci 38.2% 32.88
52-Week Low 27.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar